"Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".
"Association Between the Treatment of Peri-implantitis and the Resolution of Maxillary Sinusitis: a Case-control Study".
1 other identifier
observational
40
1 country
2
Brief Summary
Scientific evidence regarding the influence of peri-implantitis on Schneider's membrane thickening is scarce and limited. Similarly, to date, there is no literature documenting the resolution of implant-associated maxillary sinusitis with peri-implantitis after treatment of peri-implantitis or removal of the implant. Therefore, the aim of this case-control study is to investigate the association between peri-implantitis and maxillary sinusitis. On the other hand, the changes that occur at the level of the maxillary sinus membrane after treatment of peri-implantitis or after implant explantation will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2023
CompletedStudy Start
First participant enrolled
June 6, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2023
CompletedJune 29, 2023
June 1, 2023
29 days
June 6, 2023
June 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Sinus membrane thickening changes after peri-implantitis treatment
Sagital and coronal linear measurements of membrane thickening
6 months
Secondary Outcomes (2)
Severity of peri-implantitis in implants with maxillary sinusitis
1 month
Volume dimensional changes of the sinus membrane
1 month
Study Arms (2)
Case group
The case group will consist of 20 patients who will have implants diagnosed with peri-implantitis, according to the 2017 World Workshop Classification case definition.
Control group
The control group will include 20 subjects who will have implants with peri-implant health according to the 2017 World Workshop Classification case definition.
Interventions
The patient's demographic data obtained previously by anamnesis and clinical examination will be retrospectively analyzsed. On the other hand, a radiographic evaluation including analysis of the implants, adjacent teeth and maxillary sinuses/sinus membranes shall be performed using computer software.
Eligibility Criteria
All patients included in the study signed the corresponding informed consent forms for each of the treatments received, as well as for the use of their demographic and radiographic data for scientific purposes. The subjects recruited will be edentulous (partial/total) patients who previously had implants placed in the posterior region of the maxilla for oral rehabilitation. The case group will consist of 20 patients who will have implants diagnosed with peri-implantitis while in the control group the 20 subjects included will have implants with peri-implant health.
You may qualify if:
- Men and women between 18-80 years of age
- Patients with implants in the posterior sector of the upper jaw
- Dental implant carriers with a follow-up of more than 5 years
- Patients who have undergone a CT scan for the evaluation of these implants or for other reasons
You may not qualify if:
- Patients with uncontrolled systemic disease
- Pregnant or lactating patients
- Heavy smokers (HS)
- Patients with uncontrolled or active periodontal disease in need of periodontal treatment
- Patients with zygomatic or pterygoid implants
- Patients taking medications known to modify bone metabolism or who have degenerative bone disease (hyperparathyroidism, osteoporosis), vitamin D, patients who have taken antibiotics, NSAIDs or corticosteroids for more than two weeks in the last 3 months prior to the examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universitat Internacional de Catalunya (UIC)
Sant Cugat del Vallès, Barcelona, 08195, Spain
Ramon Pons
Barcelona, 08017, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jose Nart, PhD
UIC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, Clinical Professor
Study Record Dates
First Submitted
June 6, 2023
First Posted
June 29, 2023
Study Start
June 6, 2023
Primary Completion
July 5, 2023
Study Completion
July 15, 2023
Last Updated
June 29, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
Data collected from patients may only be processed by the research team of this study and will not be shared with other researchers.